We wish to clarify and officially state that Pro Lucent Pharma Limited has not been shut down or dissolved. Rather, as part of a carefully considered internal corporate strategy aimed at enhancing operational efficiency and streamlining our services, Pro Lucent Pharma Limited has been strategically merged into its parent company, LUCENT BIOPHARMA LTD.

This merger is a proactive business decision designed to consolidate our resources, align our brand identity, and strengthen our capacity to serve our customers more effectively. It is not the result of financial difficulty, regulatory action, or any negative external circumstance. On the contrary, this step reflects our commitment to growth, innovation, and improved service delivery in the pharmaceutical and biotech space.

All existing partnerships, contracts, services, and customer obligations under Pro Lucent Pharma Limited remain valid and binding under Lucent Biopharma Ltd, and all business operations are continuing seamlessly under the unified brand.

We strongly encourage all customers, suppliers, stakeholders, and the general public to disregard any misleading information that suggests Pro Lucent Pharma Limited has been shut down. We assure you that our services, product offerings, and business commitments remain fully active and operational — now under the strengthened structure of Lucent Biopharma Ltd.

We sincerely thank you for your continued trust and support.

Lucent Biopharma Ltd
On behalf of the legacy of Pro Lucent Pharma Limited